SCHEMBL6017031

SCHEMBL6017031

CN(CC(=O)NC1CCCC1)c1[c]c(Cl)nc(Cc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
POLB P06746 1/20 0.41
TBXA2R P21731 1/20 0.40
PTGDR Q13258 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
ACKR3 P25106 4/20 0.39
CCR2 P41597 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
EPHX1 P07099 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ITK Q08881 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5961348 0.94 HDAC1 (0.43) GAAPOLBTBXA2RPTGDRPTGDR2
SCHEMBL5961338 0.93 TBXA2R (0.40) POLBTBXA2RPTGDRPTGDR2ACKR3
SCHEMBL6016975 0.92 EPHX2 (0.43) GAAPOLBACKR3NPC1EPHX1
SCHEMBL6016947 0.90 KMT2A (0.41) POLBPTGDR2ACKR3NPC1RAB9A
SCHEMBL5961345 0.89 ACKR3 (0.42) POLBPTGDR2ACKR3NPC1RAB9A
SCHEMBL5961320 0.86 EPHX1 (0.41) GAAALDH1A1NPC1EPHX1CYP2C9
SCHEMBL5961317 0.86 EPHX2 (0.41) GAAPOLBACKR3NPC1EPHX1
SCHEMBL6016971 0.85 HDAC1 (0.44) GAAPTGDR2ACKR3ALDH1A1NPC1
SCHEMBL6016869 0.84 GAA (0.40) GAAPOLBNPC1EPHX1RAB9A
SCHEMBL5961329 0.84 RAB9A (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471057-A1 Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2 Bayer HealthCare AG (DE) 2004-10-27 EP claimed
EP-1633726-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 Actimis Pharmaceuticals, Inc., (US) 2006-03-15 EP disclosed
WO-2004096777-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2004-11-11 WO disclosed